Nucleic Acid Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Nucleic Acid Therapeutics Market Report 2026

Name: Nucleic Acid Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy Type (Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Gene Therapies, Aptamers, Other Therapy Types), By Therapeutic Area (Neuromuscular Disorder, Metabolic Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Oncological Disorders, Other Therapeutic Areas), By Route Of Administration (Intravenous, Subcutaneous, Other Route Of Administrations), By Delivery Method (Viral Vector-Based Delivery Systems, Non-Viral Delivery Systems), By End-Use (Pharmaceutical Companies, Government And Academic Research Institutes, Biotech Companies) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Nucleic Acid Therapeutics Market Overview

• Nucleic Acid Therapeutics market size has reached to $6.94 billion in 2025

• Expected to grow to $14.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%

• Growth Driver: Rise In Genetic And Chronic Diseases Fueling The Growth Of The Market Due To Advancements In Genetic Testing And Personalized Treatment Needs

• Market Trend: Transforming Rare Disease Treatment Through Gene Expression Modulation

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nucleic Acid Therapeutics Market?

Nucleic acid therapeutics refers to a class of treatments that use nucleic acids such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or their synthetic analogues to modulate gene expression or correct genetic mutations in order to treat diseases at the molecular level. Nucleic acid therapeutics utilize synthetic strands of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) to target and regulate specific genetic sequences within the body, enabling the treatment of diseases at the molecular and genetic level.

The main therapy types of nucleic acid therapeutics are antisense oligonucleotides (ASOs), small interfering RNA (siRNA), gene therapies, aptamers, and others. Antisense oligonucleotides (ASOs) are short, synthetic strands of nucleic acids designed to bind to specific messenger RNA (mRNA) molecules to block or modify the expression of target genes. These therapies are used across various therapeutic areas such as neuromuscular disorders, metabolic disorders, cardiovascular disorders, ophthalmological disorders, and oncological disorders, and others are administered through different routes including intravenous, subcutaneous, and others, using various delivery methods such as viral vector-based and non-viral delivery systems, with key end use in pharmaceutical companies, government and academic research institutes, and biotech companies.

Nucleic Acid Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Nucleic Acid Therapeutics Market Size and Share 2026?

The nucleic acid therapeutics market size has grown rapidly in recent years. It will grow from $6.94 billion in 2025 to $8.01 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to limited availability of nucleic acid therapeutics, reliance on traditional small molecule therapies, growing demand for precision medicine, regulatory approvals for early gene therapies, increasing academic research on gene modulation.

What Is The Nucleic Acid Therapeutics Market Growth Forecast?

The nucleic acid therapeutics market size is expected to see rapid growth in the next few years. It will grow to $14.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to development of crispr and other gene editing technologies, expansion of lipid nanoparticle (lnp) delivery systems, rising adoption of personalized nucleic acid therapies, increasing collaborations between pharma and biotech, growing investment in rna-based therapeutics. Major trends in the forecast period include rising adoption of antisense oligonucleotides (asos) and sirna therapies, expansion of crispr-based and gene editing therapeutics, growth in targeted therapies for neuromuscular, metabolic, and oncological disorders, increasing investment in non-viral and viral delivery systems, emergence of long non-coding rna (lncrna) and microrna (mirna) therapeutics.

Book your 30 minutes free consultation with our research experts

Global Nucleic Acid Therapeutics Market Segmentation

1) By Therapy Type: Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Gene Therapies, Aptamers, Other Therapy Types

2) By Therapeutic Area: Neuromuscular Disorder, Metabolic Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Oncological Disorders, Other Therapeutic Areas

3) By Route Of Administration: Intravenous, Subcutaneous, Other Route Of Administrations

4) By Delivery Method: Viral Vector-Based Delivery Systems, Non-Viral Delivery Systems

5) By End-Use: Pharmaceutical Companies, Government And Academic Research Institutes, Biotech Companies

Subsegments:

1) By Antisense Oligonucleotides (ASOs): Phosphorothioate ASOs, 2’-O-Methyl ASOs, Locked Nucleic Acid (LNA) ASOs, Gapmer ASOs, Morpholino ASOs

2) By Small Interfering RNA (siRNA): Lipid Nanoparticle (LNP) Formulated siRNA, GalNAc-Conjugated siRNA, Chemically Modified siRNA, Naked siRNA

3) By Gene Therapies: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, CRISPR-Based Gene Therapy, Zinc Finger Nucleases (ZFNs), TALENs

4) By Aptamers: Ribonucleic Acid (RNA) Aptamers, Deoxyribonucleic Acid (DNA) Aptamers, Spiegelmers, Pegylated Aptamers

5) By Others Therapy Types: MicroRNA (miRNA) Therapeutics, Long Non-Coding RNA (lncRNA) Therapeutics, Ribonucleic Acid (RNA) Editing Therapies, Ribozymes

What Is The Driver Of The Nucleic Acid Therapeutics Market?

The increasing number of genetic and chronic diseases is expected to propel the growth of the nucleic acid therapeutics market going forward. Genetics and chronic diseases refer to the relationship between inherited genetic factors and the development, progression, or risk of long-term health conditions such as diabetes, cardiovascular diseases, cancer, and autoimmune disorders. The rise in genetics-related and chronic diseases is largely due to improved diagnostic technologies that identify these conditions more accurately and earlier. Nucleic acid therapeutics are useful for genetics and chronic diseases because they can target and modify the underlying genetic causes of these conditions by regulating, repairing, or silencing specific genes, offering precise and personalized treatment options. For instance, October 2024, according to the Cystic Fibrosis Trust is a UK-based charity dedicated to supporting people with cystic fibrosis, in 2022, 11,148 cystic fibrosis patients were registered, and this number grew to 11,318 in 2023, reflecting a 1.5% increase in patient registrations year-over-year. Therefore, the increasing number of genetic and chronic diseases is driving the growth of the nucleic acid therapeutics industry.

Key Players In The Global Nucleic Acid Therapeutics Market

Major companies operating in the nucleic acid therapeutics market are Pfizer Inc., Novartis AG, Moderna Inc., BioNTech SE, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc.

Global Nucleic Acid Therapeutics Market Trends and Insights

Major companies operating in the nucleic acid therapeutics market are focusing on developing innovative products such as antisense oligonucleotide therapy to target and silence specific disease-causing genes, offering precision treatment options for genetic disorders and rare diseases. Antisense oligonucleotide therapy is a precision treatment that uses short, synthetic strands of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) to block or modify the expression of specific genes involved in disease. For instance, in December 2024, Ionis Pharmaceuticals Inc., a US-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for TRYNGOLZ (olezarsen) as an adjunct therapy to diet for lowering triglyceride levels in adults diagnosed with familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by severe hypertriglyceridemia (sHTG) and a high risk of acute pancreatitis (AP). It represents the first FDA-approved treatment to deliver significant and sustained triglyceride reduction in this patient population, alongside a clinically meaningful decrease in AP incidence when combined with a low-fat diet. The therapy is designed for convenient self-administration via a once-monthly auto-injector.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Nucleic Acid Therapeutics Market?

In June 2025, Novartis AG, a Switzerland-based company that develops and manufactures innovative drugs, acquired Regulus Therapeutics Inc. for an undisclosed amount. Through this acquisition, it aims to enhance its capabilities in RNA-targeted drug development, strengthen its pipeline in rare and chronic diseases, and accelerate the advancement of next-generation therapies using Regulus's expertise in microRNA-based therapeutics. Regulus Therapeutics Inc. is a US-based biotechnology company focused on the development of microRNA therapies.

Regional Insights

North America was the largest region in the nucleic acid therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nucleic Acid Therapeutics Market?

The nucleic acid therapeutics market consists of revenues earned by entities by providing services such as custom oligonucleotide synthesis, gene silencing and editing services, drug discovery and development support, messenger RNA (mRNA) and small interfering RNA (siRNA) design and optimization, and delivery system development. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid therapeutics market also includes sales of messenger RNA (mRNA) therapeutics, clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing tools (therapeutic use), aptamers, and Amondys 45 (casimersen). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nucleic Acid Therapeutics Market Report 2026?

The nucleic acid therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Nucleic Acid Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.01 billion
Revenue Forecast In 2035	$14.07 billion
Growth Rate	CAGR of 15.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy Type, Therapeutic Area, Route Of Administration, Delivery Method, End-Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Novartis AG, Moderna Inc., BioNTech SE, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biop
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nucleic Acid Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nucleic Acid Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nucleic Acid Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nucleic Acid Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Antisense Oligonucleotides (Asos) And Sirna Therapies

4.2.2 Expansion Of Crispr-Based And Gene Editing Therapeutics

4.2.3 Growth In Targeted Therapies For Neuromuscular, Metabolic, And Oncological Disorders

4.2.4 Increasing Investment In Non-Viral And Viral Delivery Systems

4.2.5 Emergence Of Long Non-Coding Rna (Lncrna) And Microrna (Mirna) Therapeutics

5. Nucleic Acid Therapeutics Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotech Companies

5.3 Government And Academic Research Institutes

5.4 Clinical Research Organizations (Cros)

5.5 Hospitals And Specialty Treatment Centers

6. Nucleic Acid Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nucleic Acid Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nucleic Acid Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nucleic Acid Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nucleic Acid Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nucleic Acid Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nucleic Acid Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nucleic Acid Therapeutics Market Segmentation

9.1. Global Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Gene Therapies, Aptamers, Other Therapy Types

9.2. Global Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neuromuscular Disorder, Metabolic Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Oncological Disorders, Other Therapeutic Areas

9.3. Global Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Subcutaneous, Other Route Of Administrations

9.4. Global Nucleic Acid Therapeutics Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vector-Based Delivery Systems, Non-Viral Delivery Systems

9.5. Global Nucleic Acid Therapeutics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Companies, Government And Academic Research Institutes, Biotech Companies

9.6. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Antisense Oligonucleotides (ASOs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phosphorothioate ASOs, 2’-O-Methyl ASOs, Locked Nucleic Acid (LNA) ASOs, Gapmer ASOs, Morpholino ASOs

9.7. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Small Interfering RNA (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lipid Nanoparticle (LNP) Formulated siRNA, GalNAc-Conjugated siRNA, Chemically Modified siRNA, Naked siRNA

9.8. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, CRISPR-Based Gene Therapy, Zinc Finger Nucleases (ZFNs), TALENs

9.9. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ribonucleic Acid (RNA) Aptamers, Deoxyribonucleic Acid (DNA) Aptamers, Spiegelmers, Pegylated Aptamers

9.10. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

MicroRNA (miRNA) Therapeutics, Long Non-Coding RNA (lncRNA) Therapeutics, Ribonucleic Acid (RNA) Editing Therapies, Ribozymes

10. Nucleic Acid Therapeutics Market Regional And Country Analysis

10.1. Global Nucleic Acid Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nucleic Acid Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nucleic Acid Therapeutics Market

11.1. Asia-Pacific Nucleic Acid Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nucleic Acid Therapeutics Market

12.1. China Nucleic Acid Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nucleic Acid Therapeutics Market

13.1. India Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nucleic Acid Therapeutics Market

14.1. Japan Nucleic Acid Therapeutics Market Overview

14.2. Japan Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nucleic Acid Therapeutics Market

15.1. Australia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nucleic Acid Therapeutics Market

16.1. Indonesia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nucleic Acid Therapeutics Market

17.1. South Korea Nucleic Acid Therapeutics Market Overview

17.2. South Korea Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nucleic Acid Therapeutics Market

18.1. Taiwan Nucleic Acid Therapeutics Market Overview

18.2. Taiwan Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nucleic Acid Therapeutics Market

19.1. South East Asia Nucleic Acid Therapeutics Market Overview

19.2. South East Asia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nucleic Acid Therapeutics Market

20.1. Western Europe Nucleic Acid Therapeutics Market Overview

20.2. Western Europe Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nucleic Acid Therapeutics Market

21.1. UK Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nucleic Acid Therapeutics Market

22.1. Germany Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nucleic Acid Therapeutics Market

23.1. France Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nucleic Acid Therapeutics Market

24.1. Italy Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nucleic Acid Therapeutics Market

25.1. Spain Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nucleic Acid Therapeutics Market

26.1. Eastern Europe Nucleic Acid Therapeutics Market Overview

26.2. Eastern Europe Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nucleic Acid Therapeutics Market

27.1. Russia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nucleic Acid Therapeutics Market

28.1. North America Nucleic Acid Therapeutics Market Overview

28.2. North America Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nucleic Acid Therapeutics Market

29.1. USA Nucleic Acid Therapeutics Market Overview

29.2. USA Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nucleic Acid Therapeutics Market

30.1. Canada Nucleic Acid Therapeutics Market Overview

30.2. Canada Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nucleic Acid Therapeutics Market

31.1. South America Nucleic Acid Therapeutics Market Overview

31.2. South America Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nucleic Acid Therapeutics Market

32.1. Brazil Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nucleic Acid Therapeutics Market

33.1. Middle East Nucleic Acid Therapeutics Market Overview

33.2. Middle East Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nucleic Acid Therapeutics Market

34.1. Africa Nucleic Acid Therapeutics Market Overview

34.2. Africa Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nucleic Acid Therapeutics Market Regulatory and Investment Landscape

36. Nucleic Acid Therapeutics Market Competitive Landscape And Company Profiles

36.1. Nucleic Acid Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Nucleic Acid Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Nucleic Acid Therapeutics Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Nucleic Acid Therapeutics Market Other Major And Innovative Companies

Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc.

38. Global Nucleic Acid Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nucleic Acid Therapeutics Market

40. Nucleic Acid Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Nucleic Acid Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Nucleic Acid Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Nucleic Acid Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Nucleic Acid Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Nucleic Acid Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Nucleic Acid Therapeutics Market, Supply Chain Analysis

Table 4: Global Nucleic Acid Therapeutics Market, Major Raw Material Providers

Table 5: Global Nucleic Acid Therapeutics Market, Major Resource Providers

Table 6: Global Nucleic Acid Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Nucleic Acid Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Nucleic Acid Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Nucleic Acid Therapeutics Market, Major Trends

Table 10: Global Nucleic Acid Therapeutics Market, Major End Users

Table 11: Global Nucleic Acid Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Nucleic Acid Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Nucleic Acid Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Nucleic Acid Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Nucleic Acid Therapeutics Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Nucleic Acid Therapeutics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Antisense Oligonucleotides (ASOs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Small Interfering RNA (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Nucleic Acid Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Nucleic Acid Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Nucleic Acid Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Nucleic Acid Therapeutics Market - Company Scoring Matrix

Table 101: Pfizer Inc. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Moderna Inc. Financial Performance

Table 104: BioNTech SE Financial Performance

Table 105: Alnylam Pharmaceuticals Inc. Financial Performance

Table 106: Global Nucleic Acid Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Nucleic Acid Therapeutics Market, Competitive Dashboard

Table 108: Global Nucleic Acid Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Nucleic Acid Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Table 110: Global, Nucleic Acid Therapeutics Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030

Table 111: Global, Nucleic Acid Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Nucleic Acid Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Nucleic Acid Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Nucleic Acid Therapeutics Market, Supply Chain Analysis

Figure 4: Global Nucleic Acid Therapeutics Market, Major Raw Material Providers

Figure 5: Global Nucleic Acid Therapeutics Market, Major Resource Providers

Figure 6: Global Nucleic Acid Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Nucleic Acid Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Nucleic Acid Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Nucleic Acid Therapeutics Market, Major Trends

Figure 10: Global Nucleic Acid Therapeutics Market, Major End Users

Figure 11: Global Nucleic Acid Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Nucleic Acid Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Nucleic Acid Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Nucleic Acid Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Nucleic Acid Therapeutics Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Nucleic Acid Therapeutics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Antisense Oligonucleotides (ASOs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Small Interfering RNA (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Nucleic Acid Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Nucleic Acid Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Nucleic Acid Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Nucleic Acid Therapeutics Market - Company Scoring Matrix

Figure 101: Pfizer Inc. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Moderna Inc. Financial Performance

Figure 104: BioNTech SE Financial Performance

Figure 105: Alnylam Pharmaceuticals Inc. Financial Performance

Figure 106: Global Nucleic Acid Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Nucleic Acid Therapeutics Market, Competitive Dashboard

Figure 108: Global Nucleic Acid Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Nucleic Acid Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Figure 110: Global, Nucleic Acid Therapeutics Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030

Figure 111: Global, Nucleic Acid Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Sandwich Panels Market Report 2026 - Global Outlook – By Core Material (Polyurethane, Polyisocyanurate, Mineral Wool, Expanded Polystyrene ), By Skin Material (Continuous Fiber Reinforced Thermoplastics (CFRT), Fiberglas...

Metal Structural Insulation Panels Market Report 2026 - Global Outlook – By Facing Material (Oriented Strand Board (OSB), Magnesium Oxide Board (MgO Board), Other Facing Materials), By Application (Floor, Roof, Wall ), B...

Building Insulation Materials Market Report 2026 - Global Outlook – By Material (Fiberglass, Mineral Wool, Expanded Polystyrene, Extruded Polystyrene, Cellulose, Other Materials), By Insulation (Bulk, Reflective), By App...

Insulation Products Market Report 2026 - Global Outlook – By Insulation Type (Thermal, Acoustic, Other Insulation Types), By Material Type (Mineral Wool, Fiberglass, Stone Wool, Polyurethane Foam, Flexible Elastomeric Fo...

Refrigeration Insulation Materials Market Report 2026 - Global Outlook – By Type (Elastomeric Foam, Polyurethane And Polyisocyanurate (PU And PIR), Polystyrene Foam, Fiberglass, Phenolic Foam, Other Types), By Applicatio...

Technical Insulation Market Report 2026 - Global Outlook – By Product (Flexible Foam, Rigid Foam, Man-made Mineral Fiber ), By Application (Heating & Plumbing, HVAC, Refrigeration, Industrial Processes), By End User (Ind...

Structural Insulated Panels Market 2023 – By Insulation Materials (Expanded Polystyrene (EPS) Panel, Rigid Polyurethane (PUR), Rigid Polyisocyanurate (PIR) Panel, Glass Wool, Stone Wool, Extruded Polystyrene Foam Panel, ...

Frequently Asked Questions

How big is the Nucleic Acid Therapeutics Market?

The Nucleic Acid Therapeutics market was valued at $6.94 billion in 2025, increased to $8.01 billion in 2026, and is projected to reach $14.07 billion by 2030.

What is the Nucleic Acid Therapeutics market growth?

The global Nucleic Acid Therapeutics market is expected to grow at a CAGR of 15.1% from 2026 to 2035 to reach $14.07 billion by 2035.

Who are the key players in Nucleic Acid Therapeutics market?

Some Key Players in the Nucleic Acid Therapeutics market Include, Pfizer Inc., Novartis AG, Moderna Inc., BioNTech SE, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc. .

What is the anticipated growth trend for the Nucleic Acid Therapeutics market?

Major trend in this market includes: Transforming Rare Disease Treatment Through Gene Expression Modulation. For further insights on this market. request a sample here

Which region has the most growth potential in the Nucleic Acid Therapeutics market?

North America was the largest region in the nucleic acid therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.